HealthEquity, Inc. (HQY)

From the record

HealthEquity, Inc.'s filings since 2017 show 1 warning event: a debt default or acceleration notice (8-K item 2.04, the latest 2021-11-01) (its current reports).

From the record

HealthEquity, Inc.'s 10 filed years say what it did: revenue went from $178 million in fiscal 2017 to $1.3 billion in fiscal 2026, up 24.8% a year; it rose in 9 of 9 years; it never fell from a peak; net income was positive in 8 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2026-01-31, HealthEquity, Inc.'s diluted share count grew about 1.2% a year, and dividends and buybacks returned about 40% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 14 sales (10 under scheduled 10b5-1 plans) and 2 purchases of their own stock on the open market in the year to 2026-10-19, buying about $12 thousand (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2026-01-31, HealthEquity, Inc. earned about 10 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 27 cents per dollar of everything the company owns. Leverage: it owed about 38 cents per dollar of assets, and net share issuance: its share count shrank 1.5% over the year (the filed statements).

From the record

HealthEquity, Inc.'s standing among 101 graded names in its industry family: revenue of $1.3 billion in fiscal 2026 ranks in the top 45% by size; a net margin of 16.4% ranks in the top 18%; revenue growth of 15.1% a year over the last 3 filed years ranks in the top 35% (its annual reports).

From the record

HealthEquity, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Cutler, Scott (President and CEO, as filed), filing under that title since 2025-01-10, 1.8 years (bottom 28% of its family); the 17 officers and directors filing in the last fifteen months have been on the record a median of 4.7 years (bottom 36%); 9 officer or director changes were reported on Form 8-K since 2023-11-13, against the 17 people in charge now (bottom 42%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

HealthEquity, Inc.'s room to grow, from the newest filed statements (fiscal 2026): cash of $319 million against debt of $957 million leaves -18.9% of its assets as net cash, bottom 23% of its family; cash from operations less capital spending is 34.7% of revenue (top 9%); a gross margin of 69.5% (top 25%); research spending of 20% of revenue (top 27%) (its annual report).

From the record

HealthEquity, Inc.'s growth drivers, from the filed years to fiscal 2026: revenue grew 15.1% a year over the last three filed years against 24.8% over all 10, slowing (bottom 27% of its family); the newest year grew 9.5% (top 47%); research spending grew 10.7% a year (top 32%); capital spending grew -16.4% a year (bottom 23%) (its annual reports). HealthEquity, Inc. reported 3 product lines in fiscal 2026: Financial Service Other at $637 million (49%), Service at $485 million (37%), Credit and Debit Card at $192 million (15%); 3 of 3 grew against the year before (its annual report).

From the record

HealthEquity, Inc.'s newest year against its own record: revenue of $1.3 billion in fiscal 2026 came in 7.2% below the $1.4 billion its prior three years' pace pointed to (bottom 21% of its family); net income of $215 million against a prior three-year average of $42 million (top 8%); a net margin of 16.4% against 3.5% before (top 32%) (its annual reports).